Ads
related to: what is mrna-1273
Search results
Moderna's (MRNA) Omicron Based Jab gets Approval in Australia
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) receives provisional approval in Australia for its Omicron-containing bivalent...
Moderna (MRNA) Seeks FDA Nod for Omicron-Based COVID Jab
Zacks via Yahoo Finance· 2 years agoModerna's (MRNA) bivalent COVID-19 booster vaccine, mRNA-1273.222, is designed to target the Omicron...
Moderna's (MRNA) BA.1 Omicron Booster Gets CHMP Nod for Kids
Zacks via Yahoo Finance· 1 year agoThe CHMP recommends authorizing Moderna's (MRNA) bivalent COVID-19 booster vaccine, targeting the...
Moderna's Updated COVID-19 Shot Boosts Omicron Protection
Benzinga via Yahoo Finance· 2 years agoModerna Inc (NASDAQ: MRNA) has announced new clinical data on its omicron-containing bivalent...
Moderna's (MRNA) Omicron BA.4/5 Booster Jab Study Meets Goal
Zacks via Yahoo Finance· 1 year agoShares of Moderna MRNA were up 4.6% after management announced that the phase II/III study...
Moderna's (MRNA) COVID Jab Gets Nod For Kids in Canada
Zacks via Yahoo Finance· 2 years agoModerna MRNA received approval from Canadian regulatory authority, Health Canada, for its mRNA...
Moderna (MRNA) Updated COVID Jab Effective Against Eris Variant
Zacks via Yahoo Finance· 8 months agoModerna's (MRNA) updated monovalent COVID-19 vaccine generates a robust immune response against the...
Moderna Says Omicron Tailored COVID-19 Shots Shows Better Immune Response Than Original Vaccine
Benzinga via Yahoo Finance· 1 year agoModerna Inc (NASDAQ: MRNA) said that data shows its omicron-tailored vaccines, mRNA-1273.214 and...
Moderna (MRNA) Beats on Q1 Earnings, to Start Two Late Studies
Zacks via Yahoo Finance· 2 years agoModerna's (MRNA) Spikevax sales beat expectations. The company plans to start late-stage studies for...
Moderna (MRNA) Beats on Q2 Earnings, Starts $3B Buyback Program
Zacks via Yahoo Finance· 2 years agoModerna, Inc. MRNA reported earnings of $5.24 per share for the second quarter of 2022, beating the...
